Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark H. Mayer
Mark H. Mayer
Eli Lilly and Company
Medicine
Intensive care medicine
Alternative medicine
Anesthesia
Artificial intelligence
5
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?
2019
Clinical Pharmacology & Therapeutics
Hans-Georg Eichler
Nicola Bedlington
Mathieu Boudes
Jacoline C. Bouvy
André W. Broekmans
Francesca Cerreta
Stuart Faulkner
Susan R. Forda
Angelika Joos
Yann Le Cam
Mark H. Mayer
Vinciane Pirard
Solange Corriol‐Rohou
Show All
Source
Cite
Save
Citations (3)
Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views:
2018
Therapeutic Innovation & Regulatory Science
Mark H. Mayer
Angelica Canedo
Tam Dinh
Madelyn Low
Ariel Ortiz
Chloé Garay
Show All
Source
Cite
Save
Citations (0)
Supplemental Material, 812778_supplemental_appendices - Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views
2018
Mark H. Mayer
Angelica Canedo
Tam Dinh
Madelyn Low
Ariel Ortiz
Chloé Garay
Show All
Source
Cite
Save
Citations (0)
Measuring the Patient Health, Societal and Economic Benefits of US Pediatric Therapeutics Legislation
2012
Pediatric Drugs
John A. Vernon
Scott Shortenhaus
Mark H. Mayer
Albert J. Allen
Joseph H. Golec
Show All
Source
Cite
Save
Citations (8)
Recommendations regarding technical standards for follow-on biologics: comparability, similarity, interchangeability
2009
Current Medical Research and Opinion
Gregory C. Davis
John Michael Beals
Craig Johnson
Mark H. Mayer
Bruce I. Meiklejohn
Bruce H. Mitlak
Jody L. Roth
John K. Towns
Melissa Veenhuizen
Show All
Source
Cite
Save
Citations (9)
1